Thromboxane B2-d9

Thromboxane B2-d9

• Product Name Alternative: PD-189659
• UNSPSC Description: Thromboxane B2-d9 is deuterium labeled Thromboxane B2. Thromboxane B2 is a prostaglandin derivative that is released during anaphylaxis. Thromboxane B2 induces arterial contraction and platelet aggregation[1].
• Target Antigen: Isotope-Labeled Compounds; Prostaglandin Receptor
• Type: Isotope-Labeled Compounds
• Related Pathways: GPCR/G Protein;Others
• Field of Research: Inflammation/Immunology
• Smiles: O[C@@H]1[C@@H]([C@H](OC(C1)O)/C=C/[C@H](CC([2H])(C([2H])(C([2H])(C([2H])([2H])[2H])[2H])[2H])[2H])O)C/C=C\CCCC(O)=O
• Molecular Weight: 379.54
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported